AARD · ISSUER CIK 1774857
Aardvark Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Aardvark Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $395K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$395KInsider selling
−$395KNet open-market
Sep 11, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 202620:14 | Sep 11, 2026from Sep 10, 2026 | AARD | See Remarks | S · Sell10b5-1 | $5.15 | −76,754 | 35,475 | -68% | −$395K |